(Q15410963)

English

(3S,10S,13R,14R,17S)-17-[(E,2R)-7-hydroxy-6-methylhept-5-en-2-yl]-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-3-ol

chemical compound

Statements

Ganodermadiol.svg
512 × 394; 5 KB
0 references
440.365431±0 dalton
1 reference
(2S,5S,11R,14S,15R)-14-[(2R,5E)-7-HYDROXY-6-METHYLHEPT-5-EN-2-YL]-2,6,6,11,15-PENTAMETHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-1(17),9-DIEN-5-OL (English)
21 September 2016
C₃₀H₄₈O₂
1 reference
(2S,5S,11R,14S,15R)-14-[(2R,5E)-7-HYDROXY-6-METHYLHEPT-5-EN-2-YL]-2,6,6,11,15-PENTAMETHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-1(17),9-DIEN-5-OL (English)
21 September 2016
CC(CCC=C(C)CO)C1CCC2(C1(CC=C3C2=CCC4C3(CCC(C4(C)C)O)C)C)C
1 reference
(2S,5S,11R,14S,15R)-14-[(2R,5E)-7-HYDROXY-6-METHYLHEPT-5-EN-2-YL]-2,6,6,11,15-PENTAMETHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-1(17),9-DIEN-5-OL (English)
21 September 2016
C[C@H](CC/C=C(\C)/CO)[C@@H]1CC[C@@]2([C@@]1(CC=C3C2=CCC4[C@@]3(CC[C@@H](C4(C)C)O)C)C)C
1 reference
(2S,5S,11R,14S,15R)-14-[(2R,5E)-7-HYDROXY-6-METHYLHEPT-5-EN-2-YL]-2,6,6,11,15-PENTAMETHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-1(17),9-DIEN-5-OL (English)
21 September 2016

Identifiers

1 reference
(2S,5S,11R,14S,15R)-14-[(2R,5E)-7-HYDROXY-6-METHYLHEPT-5-EN-2-YL]-2,6,6,11,15-PENTAMETHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-1(17),9-DIEN-5-OL (English)
21 September 2016
1 reference
(2S,5S,11R,14S,15R)-14-[(2R,5E)-7-HYDROXY-6-METHYLHEPT-5-EN-2-YL]-2,6,6,11,15-PENTAMETHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-1(17),9-DIEN-5-OL (English)
21 September 2016
1 reference
(3beta,5xi,17alpha,24E)-Lanosta-7,9(11),24-triene-3,26-diol (English)
21 September 2016
1 reference
(2S,5S,11R,14S,15R)-14-[(2R,5E)-7-HYDROXY-6-METHYLHEPT-5-EN-2-YL]-2,6,6,11,15-PENTAMETHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-1(17),9-DIEN-5-OL (English)
21 September 2016
 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit